SAFEGUARD SCIENTIFICS ANNOUNCES TRANSFER TO NASDAQ

Written by Customer Service on October 14, 2022. Posted in Public Companies.

SFE ticker symbol remains the same RADNOR, Pa., Oct. 14, 2022 (GLOBE NEWSWIRE) — Safeguard Scientifics, Inc. (NYSE: SFE) today announced that it will transfer its common stock exchange listing from the New York Stock Exchange to the NASDAQ Capital Market (“NASDAQ”). Safeguard expects to commence trading as a NASDAQ-listed company upon market open on October 26, 2022. Safeguard’s common stock will continue to trade under the ticker symbol SFE. “This transfer to NASDAQ will provide further cost savings for our shareholders and greater corporate flexibility as we pursue portfolio exits and value maximization strategies going forward,” commented Eric Salzman, Chief Executive Officer. About Safeguard Scientifics Historically, Safeguard Scientifics has provided capital and relevant expertise to fuel the growth of technology-driven businesses....

Closing of $400 million notes of CNH Industrial Capital LLC

Written by Customer Service on October 14, 2022. Posted in Public Companies.

London, October 14, 2022 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) today announced that its wholly owned subsidiary, CNH Industrial Capital LLC, has completed its previously announced offering of $400 million in aggregate principal amount of 5.450% notes due 2025, with an issue price of 99.349%. The net proceeds of this offering were approximately $395 million after payment of offering and other related expenses. CNH Industrial Capital LLC intends to add the net proceeds from the offering to its general funds and use them for working capital and other general corporate purposes, including, among other things, the purchase of receivables or other assets in the ordinary course of business. The net proceeds may also be applied to repay CNH Industrial Capital LLC’s indebtedness as it becomes due. The notes, which are senior unsecured obligations...

Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination

Written by Customer Service on October 14, 2022. Posted in Public Companies.

TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate amount of $1,035,000 (representing $0.10 per public share) (the “Extension Payment”) into the Company’s trust account for its public stockholders. This deposit enables the Company to extend the date by which the Company has to complete its initial business combination from October 13, 2022 to January 13, 2023 (the “Extension”). The Extension is the first of two three-month extensions permitted under the Company’s governing documents. The Extension provides the Company with additional time to complete its initial business combination with Apollomics Inc. (“Apollomics”), previously announced...

Syneos Health Appoints William E. Klitgaard Independent Director

Written by Customer Service on October 14, 2022. Posted in Public Companies.

MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E. Klitgaard to its Board of Directors. Mr. Klitgaard was previously a member of the Syneos Board from 2017 until May 2022, having resigned due to a personal matter. The Company also announced today that Todd M. Abbrecht is stepping down from its Board of Directors. “We are excited to welcome Bill back to the Syneos Health Board,” said John Dineen, Chair of the Syneos Health Board of Directors. “Bill’s deep financial expertise combined with his knowledge of our company are a welcome addition to an already strong Board, enhancing its composition. This appointment will support continued successful oversight of our strategy as we speed our...

Progress Acquisition Corp. Announces Mailing of Its Extension Definitive Proxy Statement for a Shareholder Meeting on October 27, 2022

Written by Customer Service on October 14, 2022. Posted in Public Companies.

Boston, MA, Oct. 14, 2022 (GLOBE NEWSWIRE) — Progress Acquisition Corp. (“Progress” or the “Company”) (Nasdaq: “PGRW”, “PGRWU”, “PGRWW”) announced the mailing of a definitive proxy statement, dated October 12, 2022 (the “Extension Proxy Statement”), to hold a special meeting in lieu of annual meeting of stockholders (on October 27, 2022 (the “Meeting”) to approve an extension of the date by which Progress must consummate an initial business combination to on or before May 8, 2023 (the “Extended Date”) (the “Charter Extension”). Progress commenced mailing of the Extension Proxy Statement on October 13, 2022. The Meeting will be held virtually on October 27, 2022 at 10:00 AM, Eastern Time and can be accessed by visiting https://www.cstproxy.com/progressacquisition/2022. The Company’s stockholders of record at the close of business...

Transocean Ltd. Announces Third Quarter 2022 Earnings Release Date

Written by Customer Service on October 14, 2022. Posted in Public Companies.

STEINHAUSEN, Switzerland, Oct. 14, 2022 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the third quarter of 2022, after the close of trading on the NYSE on Wednesday, November 2, 2022. The company will conduct a teleconference to discuss the results starting at 9 a.m. EDT, 2 p.m. CET, on Thursday, November 3, 2022. Individuals who wish to participate should dial +1 785-424-1205 and refer to conference code 260431 approximately 15 minutes prior to the scheduled start time. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EDT, 5 p.m. CET, on November 3, 2022. The replay, which will be archived for approximately 30 days, can be accessed at +1 402-220-4975,...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

Written by Customer Service on October 14, 2022. Posted in Earnings Releases And Operating Results.

OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) — Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2022. Financial Results Revenue Consolidated revenues for the third quarter of fiscal 2022 were $7.7 million compared to $7.5 million for the third quarter of fiscal 2021. The revenues for the third quarter of fiscal 2022 consisted of $7.5 million in processing and storage fees, $21,000 in product revenue and $137,825 in public banking revenue compared to $7.3 million in processing and storage fees, $18,200 in product revenue and $158,936 in public banking revenue for the third quarter of fiscal 2021. Net Income The Company reported net income for...

Hingham Savings Reports Third Quarter 2022 Results

Written by Customer Service on October 14, 2022. Posted in Earnings Releases And Operating Results.

HINGHAM, Mass., Oct. 14, 2022 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), announced third quarter results for 2022. Earnings Net income for the quarter ended September 30, 2022 was $10,499,000 or $4.89 per share basic and $4.77 per share diluted, as compared to $14,012,000 or $6.54 per share basic and $6.36 per share diluted for the same period last year. The Bank’s annualized return on average equity for the third quarter of 2022 was 11.07%, and the annualized return on average assets was 1.05%, as compared to 16.57% and 1.85% for the same period in 2021. Net income per share (diluted) for the third quarter of 2022 decreased by 25% over the same period in 2021. Core net income for the quarter ended September 30, 2022, which represents net income excluding the after-tax gains and losses on securities,...

Rumble Announces Timing of Third Quarter 2022 Earnings Release and Conference Call

Written by Customer Service on October 14, 2022. Posted in Public Companies.

LONGBOAT KEY, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) — Rumble Inc. (“Rumble”) (NASDAQ: RUM), the video-sharing platform, today announced that it will release financial results for the third quarter of 2022 shortly after market close on Monday, November 14, 2022. The company will host a conference call the same day at 5:00 p.m. Eastern Time. Access to the live webcast and replay of the conference call, along with related earnings release materials, will be available here and on Rumble’s Investor Relations website at investors.rumble.com. About Rumble Rumble is a high-growth neutral video platform that is creating the rails and independent infrastructure designed to be immune to cancel culture. Rumble’s mission is to restore the Internet to its roots by making it free and open once again. For more information, visit corp.rumble.com. For...

Sorrento Announces Publication of Data in Cell Press Journal Med Describing Discovery and Preclinical Efficacy of a Broadly-Acting SARS-CoV-2 Neutralizing Antibody Administered IV (STI-9167) or IN (STI-9199)

Written by Customer Service on October 14, 2022. Posted in Public Companies.

SAN DIEGO, Oct. 14, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced publication in the Cell Press journal Med of data detailing work relating to the discovery and preclinical profiling of STI-9167 neutralizing antibody activity against a broad collection of SARS-CoV-2 variants, including select Omicron subvariants. Protection from Omicron-related disease in vivo in a preclinical challenge model was observed following administration of STI-9167 by the intravenous (IV) route or following administration by the intranasal (IN) route using an intranasal formulation of STI-9167 antibody, termed STI-9199. A link to the publication can be found below: https://www.cell.com/med/fulltext/S2666-6340(22)00321-X About Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial...

Day: October 14, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice